FI44670B - - Google Patents
Info
- Publication number
- FI44670B FI44670B FI2131/64A FI213164A FI44670B FI 44670 B FI44670 B FI 44670B FI 2131/64 A FI2131/64 A FI 2131/64A FI 213164 A FI213164 A FI 213164A FI 44670 B FI44670 B FI 44670B
- Authority
- FI
- Finland
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- G—PHYSICS
- G10—MUSICAL INSTRUMENTS; ACOUSTICS
- G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
- G10L15/00—Speech recognition
- G10L15/02—Feature extraction for speech recognition; Selection of recognition unit
- G10L2015/022—Demisyllables, biphones or triphones being the recognition units
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB41842/63A GB1069437A (en) | 1963-10-23 | 1963-10-23 | Injectable x-ray contrast media |
| US34421364A | 1964-02-12 | 1964-02-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI44670B true FI44670B (pt) | 1971-08-31 |
| FI44670C FI44670C (fi) | 1971-12-10 |
Family
ID=26264759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI642131A FI44670C (fi) | 1963-10-23 | 1964-10-09 | Suonensisäisesti annettava röntgenkontrastiainevalmiste. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3347746A (pt) |
| AT (1) | AT263997B (pt) |
| BE (1) | BE654702A (pt) |
| BR (1) | BR6463683D0 (pt) |
| CH (1) | CH438584A (pt) |
| DE (1) | DE1234931B (pt) |
| DK (1) | DK109526C (pt) |
| FI (1) | FI44670C (pt) |
| FR (1) | FR3758M (pt) |
| GB (1) | GB1069437A (pt) |
| IT (1) | IT1044727B (pt) |
| NL (1) | NL152753B (pt) |
| SE (1) | SE303829C (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855405A (en) * | 1969-11-26 | 1974-12-17 | Squibb & Sons Inc | Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof |
| US4278654A (en) * | 1978-07-04 | 1981-07-14 | Nyegaard & Co. A/S | Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer |
| GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
| GB2465663A (en) * | 2008-11-26 | 2010-06-02 | Ge Healthcare As | X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2132351A (en) * | 1934-07-14 | 1938-10-04 | Winthrop Chem Co Inc | Stable aqueous solutions of subtances having an anesthetic effect |
| US2268915A (en) * | 1939-05-27 | 1942-01-06 | Hahnemann Res Foundation | Method and material for detoxifying local anesthetics |
| US2820814A (en) * | 1955-03-21 | 1958-01-21 | Schering Corp | Polyiodinated 5-aminoisophthalic acids, salts, and esters |
| US3009952A (en) * | 1957-04-17 | 1961-11-21 | Sterling Drug Inc | Preparation of halogenated isophthalic acids |
| US2921884A (en) * | 1957-09-30 | 1960-01-19 | Sterling Drug Inc | Pharmaceutical compositions |
| US3033757A (en) * | 1959-04-08 | 1962-05-08 | Mallinckrodt Chemical Works | X-ray contrast agents |
| US3175952A (en) * | 1963-05-29 | 1965-03-30 | Sterling Drug Inc | Aqueous radiopaque solutions containing sodium and calcium ions |
-
1963
- 1963-10-23 GB GB41842/63A patent/GB1069437A/en not_active Expired
-
1964
- 1964-10-09 FI FI642131A patent/FI44670C/fi active
- 1964-10-12 DK DK502264AA patent/DK109526C/da active
- 1964-10-12 US US403356A patent/US3347746A/en not_active Expired - Lifetime
- 1964-10-15 FR FR991501A patent/FR3758M/fr not_active Expired
- 1964-10-16 CH CH1347464A patent/CH438584A/de unknown
- 1964-10-19 AT AT885264A patent/AT263997B/de active
- 1964-10-21 IT IT22488/64A patent/IT1044727B/it active
- 1964-10-22 BE BE654702D patent/BE654702A/xx unknown
- 1964-10-23 DE DEN25719A patent/DE1234931B/de active Pending
- 1964-10-23 SE SE1278664A patent/SE303829C/xx unknown
- 1964-10-23 BR BR163683/64A patent/BR6463683D0/pt unknown
- 1964-10-23 NL NL646412391A patent/NL152753B/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI44670C (fi) | 1971-12-10 |
| GB1069437A (en) | 1967-05-17 |
| BR6463683D0 (pt) | 1973-07-17 |
| DK109526C (da) | 1968-05-06 |
| IT1044727B (it) | 1980-04-21 |
| BE654702A (pt) | 1965-02-15 |
| NL6412391A (pt) | 1965-04-26 |
| CH438584A (de) | 1967-06-30 |
| AT263997B (de) | 1968-08-12 |
| US3347746A (en) | 1967-10-17 |
| SE303829C (sv) | 1972-04-17 |
| SE303829B (sv) | 1968-09-09 |
| FR3758M (fr) | 1965-12-13 |
| NL152753B (nl) | 1977-04-15 |
| DE1234931B (de) | 1967-02-23 |